Phase 3 RASolute 302 data show daraxonrasib significantly extended overall and progression free survival compared with chemotherapy in metastatic PDAC.

Researchers evaluated nutrition impact symptoms in patients with gastric cancer receiving chemotherapy to identify distinct symptom burden profiles.

HealthDay News — Combining chemotherapy with immunotherapy before surgery for head and neck cancer is associated with significantly greater reductions in tumor size than immunotherapy alone, according ...

In this analysis, researchers sought to assess the impact of the 21st Century Cures Act, which gave the FDA increased flexibility to accept a single pivotal trial as the basis for a novel drug ...

Researchers evaluated the real-world outcomes of lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma.

The effects of PD-1 immune checkpoint inhibitors on therapy-related MDS are not well understood. Treatment with nivolumab for metastatic melanoma may have improved a concurrent case of therapy-related ...

Stage-specific EBV miRNA patterns may help distinguish early from advanced CLL and inform disease biology. EBV-encoded microRNAs (miRNAs) demonstrated distinct associations with clinical stage in ...

A multisite, external validation study of men on prostate cancer active surveillance compared urinary MPS2-AS testing and mpMRI for upgrading.

Participants in the highest versus the lowest tertile of CDAI had significantly lower prevalence of cervical cancer.

Vanishing tumor occurred in 21% of patients, substantially delayed diagnosis, and independently predicted higher mortality.

Investigators evaluated the efficacy and safety of immune checkpoint inhibitors in high-risk patients with genitourinary cancers and advanced chronic kidney disease.

Researchers evaluated a novel prognostic model incorporating molecular signatures for patients with secondary myelofibrosis.